Navamedic ASA

Common Name
Navamedic
Country
Norway
Sector
Healthcare
Industry
Medical Distribution
Employees
42
Ticker
NAVA
Exchange
OSLO BORS
Description
Navamedic ASA is a prominent healthcare company that specializes in distributing and marketing pharmaceuticals and medical nutrition products. Headquartered in Norway, Navamedic serves a variety of ma...

Navamedic's GHG Emissions Data Preview

In 2024, Navamedic completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).

However, Navamedic has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.

Metric (tCO2e)2024202320222021 - 2017
Total Scope 1
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 2
Unspecified Calculation Method
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 3
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 1 Revenue Intensity (tCO2e/$M)
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Download Data

Verified Sources Behind Navamedic’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Navamedic’s data sources below and access millions more through our Disclosure Search.

a. Navamedic's Annual Report 2024
a. Navamedic's Annual Report 2024

Insights into Navamedic's Operational Emissions

In 2024, the total operational greenhouse gas (GHG) emissions of Navamedic amounted to 17.2 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a

Navamedic's Scope 1 Emissions Over Time

202405101520tCO2e
  • Total Scope 1
  • Year-over-Year Change

What are Navamedic's Scope 1 emissions?

In 2024, the total Scope 1 emissions of Navamedic were 16.5 metric tons of CO₂ equivalent (tCO₂e). a

What are Navamedic's Scope 2 emissions?

In 2024, Navamedic reported Scope 2 greenhouse gas (GHG) emissions of 0.7 tCO₂e without specifying the calculation method. a

What methodology does Navamedic use for Scope 2 reporting?

In 2024, Navamedic reported its Scope 2 emissions using an unspecified methodology. a

Navamedic's Scope 2 Emissions Over Time

202400.20.40.60.8tCO2e
  • Total Scope 2 (Unspecified Calculation Method)

Insights into Navamedic's Value Chain Emissions

In 2024, Navamedic reported 114 metric tons of CO₂ equivalent (tCO₂e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain. a

The 2024 disclosure of Navamedic includes a breakdown across 0 of the 15 Scope 3 categories defined by the GHG Protocol, matching the level of disclosure in , demonstrating consistent Scope 3 emissions reporting coverage year over year. a

Navamedic's Scope 3 Emissions Over Time

20240306090120tCO2e
  • Total Scope 3
  • Year-over-Year Change

What are Navamedic's Scope 3 emissions?

In 2024, Navamedic reported total Scope 3 emissions of 114 metric tons of CO₂ equivalent (tCO₂e). a

Insights into Navamedic’s GHG Emissions Intensity Compared to Industry Peers

In 2024, Navamedic reported Scope 1 greenhouse gas (GHG) emissions of 16.5 tCO₂e and total revenues of USD 47 millions. This translates into an emissions intensity of 0.35 tCO₂e per millions USD. a

Navamedic's Scope 1 Emissions Intensity Compared to Peers

51002,00020,000500,000Scope 1 Emissions (tCO2e)2502,00050,0001,000,000Revenues (Millions of USD)SMBJMAs OneYear: 2024Scope 1: 165 tCO2eRevenue: $M 631Scope 1 Intensity: 0.26 tCO2e/$MSigma HealthcareYear: 2024Scope 1: 8 tCO2eRevenue: $M 3,028Scope 1 Intensity: 0.00 tCO2e/$MSSSinopharm GroupYear: 2024Scope 1: 48,786 tCO2eRevenue: $M 87,180Scope 1 Intensity: 0.56 tCO2e/$MHLBYear: 2024Scope 1: 131 tCO2eRevenue: $M 46Scope 1 Intensity: 2.82 tCO2e/$MHenry ScheinYear: 2024Scope 1: 33,555 tCO2eRevenue: $M 12,673Scope 1 Intensity: 2.65 tCO2e/$MMcKessonYear: 2024Scope 1: 79,848 tCO2eRevenue: $M 309,009Scope 1 Intensity: 0.26 tCO2e/$MMicroPort MedBotYear: 2023Scope 1: 68 tCO2eRevenue: $M 16Scope 1 Intensity: 4.19 tCO2e/$MSuzukenYear: 2023Scope 1: 26,491 tCO2eRevenue: $M 17,378Scope 1 Intensity: 1.52 tCO2e/$MMMMicroport Cardioflow MedtechYear: 2023Scope 1: 268 tCO2eRevenue: $M 52Scope 1 Intensity: 5.18 tCO2e/$MCardinal HealthYear: 2024Scope 1: 160,150 tCO2eRevenue: $M 226,841Scope 1 Intensity: 0.71 tCO2e/$MGalenicaYear: 2024Scope 1: 6,546 tCO2eRevenue: $M 4,330Scope 1 Intensity: 1.51 tCO2e/$MAmplifonYear: 2024Scope 1: 7,507 tCO2eRevenue: $M 2,507Scope 1 Intensity: 2.99 tCO2e/$MBBBaiyunshan Pharmaceutical HoldingsYear: 2024Scope 1: 34,043 tCO2eRevenue: $M 10,276Scope 1 Intensity: 3.31 tCO2e/$MAdimmuneYear: 2023Scope 1: 4,556 tCO2eRevenue: $M 58Scope 1 Intensity: 78.30 tCO2e/$MJJJointown Pharmaceutical GroupYear: 2024Scope 1: 36,924 tCO2eRevenue: $M 20,801Scope 1 Intensity: 1.78 tCO2e/$MAlfresa HoldingsYear: 2023Scope 1: 32,399 tCO2eRevenue: $M 20,241Scope 1 Intensity: 1.60 tCO2e/$MMMMedipal HoldingsYear: 2023Scope 1: 28,439 tCO2eRevenue: $M 25,225Scope 1 Intensity: 1.13 tCO2e/$MHua MedicineYear: 2023Scope 1: 19 tCO2eRevenue: $M 12Scope 1 Intensity: 1.63 tCO2e/$MJacobio Pharmaceuticals GroupYear: 2023Scope 1: 34 tCO2eRevenue: $M 10Scope 1 Intensity: 3.48 tCO2e/$MEBOS GroupYear: 2025Scope 1: 3,343 tCO2eRevenue: $M 8,055Scope 1 Intensity: 0.42 tCO2e/$MGenor Biopharma HoldingsYear: 2022Scope 1: 18 tCO2eRevenue: $M 3Scope 1 Intensity: 7.17 tCO2e/$MNavamedicYear: 2024Scope 1: 17 tCO2eRevenue: $M 47Scope 1 Intensity: 0.35 tCO2e/$M

How does Navamedic's GHG emissions intensity compare to its peers?

In 2024, Navamedic reported a Scope 1 emissions intensity of 0.35 tCO₂e per millions USD. Compared to the peer group median of 1.63 , this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors. a

Where does Navamedic rank on GHG emissions intensity within its industry?

In 2024, Navamedic ranked 4 out of 21 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a

This places Navamedic among the top performers, with one of the lowest emissions intensities relative to peers. a

Insights into Navamedic's Total Carbon Footprint

In 2024, Navamedic reported a total carbon footprint of 131.2 metric tons of CO₂ equivalent (tCO₂e) across Scope 1, Scope 2, and Scope 3 emissions. a

The largest contributor to Navamedic's total carbon footprint was Scope 3 emissions, accounting for 86.89% of the company's total carbon footprint, followed by Scope 1 emissions at 12.58%. a

Want Full Access to Navamedic's GHG Emissions Dataset?
Sign Up